• Kymera Therapeutics Appoints Penny Carlson as Senior Vice President, Development Operations The Manila Times Tue, 09 Jun 2026 07:00:00 GMT
• kymera appoints penny carlson as svp of development operations Investing.com UK Mon, 08 Jun 2026 21:58:22 GMT
• kymera therapeutics appoints penny carlson as senior vice president, development operations The Manila Times Mon, 08 Jun 2026 20:06:38 GMT
• rein therapeutics, inc. q1 2026 10-q report: financial statements, risk factors, and forward-looking statements Minichart Fri, 15 May 2026 19:55:00 GMT
• neuraclick expands scientific and translational leadership with key advisory appointments The Manila Times Wed, 15 Apr 2026 13:10:25 GMT
• small cell lung cancer clinical trial pipeline shows potential with active contributions from 100+ key companies | delveinsight StreetInsider Thu, 05 Mar 2026 23:27:07 GMT
• bostinno - making plastic waste personal | diversifying clinical trials The Business Journals Wed, 17 Dec 2025 16:32:03 GMT
• bostinno - making plastic waste personal | diversifying clinical trials The Business Journals Tue, 21 Oct 2025 18:09:57 GMT
• rein therapeutics files to sell 10m shares of common stock for holders MSN Wed, 03 Sep 2025 21:29:42 GMT
• aileron therapeutics announces positive topline data from cohort 2 of the phase 1b clinical trial of lti-03 in idiopathic pulmonar... Quantisnow Mon, 25 Aug 2025 11:36:31 GMT
• peripheral t-cell lymphoma (ptcl) market outlook 2034 – clinical trials, market size, medication, prevalence, companies by delvein... The Globe and Mail Mon, 18 Aug 2025 07:00:00 GMT
• do options traders know something about royal gold stock we don't? The Globe and Mail Mon, 04 Aug 2025 18:18:53 GMT
• small cell lung cancer pipeline outlook report 2025: key 100+ companies and breakthrough therapies shaping the future landscape The Globe and Mail Mon, 04 Aug 2025 07:00:00 GMT
• should you buy, hold, or sell amd stock ahead of q2 earnings? The Globe and Mail Fri, 01 Aug 2025 17:44:00 GMT
• rein therapeutics enters into agreements for up to $21 million in flexible financing MSN Thu, 31 Jul 2025 13:47:29 GMT
• temu accused by eu regulators of failing to prevent sale of illegal products The Globe and Mail Mon, 28 Jul 2025 12:08:00 GMT
• hasi announces second quarter 2025 earnings release date and conference call The Globe and Mail Tue, 22 Jul 2025 07:00:00 GMT
• tecogen announces public offering of common stock The Globe and Mail Sat, 19 Jul 2025 07:00:00 GMT
• jpmorgan acquires substantial stake in boss energy The Globe and Mail Thu, 17 Jul 2025 07:00:00 GMT
• abbvie’s long-term study on bimatoprost sr: a potential game changer in glaucoma treatment The Globe and Mail Thu, 17 Jul 2025 07:00:00 GMT
• elementis executes share buyback, cancels 250,000 shares The Globe and Mail Wed, 16 Jul 2025 07:00:00 GMT
• rein therapeutics inc. announces fda clinical hold on lti-03 MarketScreener Fri, 11 Jul 2025 20:01:00 GMT
• constrained peptide drugs market size, scope and share analysis Insightace Analytic Fri, 11 Jul 2025 07:00:00 GMT
• radiant biotherapeutics appoints deborah geraghty, ph.d., as president and chief executive officer BioSpace Thu, 10 Jul 2025 07:00:00 GMT
• regional management corp. to report second quarter 2025 results on wednesday, july 30, 2025 The Globe and Mail Wed, 02 Jul 2025 07:00:00 GMT
• clarkson plc announces total voting rights update The Globe and Mail Wed, 02 Jul 2025 07:00:00 GMT
• is aileron therapeutics, inc. technically bullish or bearish? MarketsMojo Wed, 25 Jun 2025 07:00:00 GMT
• rein therapeutics announces adjournment of annual meeting of stockholders Seeking Alpha Tue, 24 Jun 2025 14:11:00 GMT
• plug power: here's how plug stock can rise 10x in 3 years The Globe and Mail Tue, 24 Jun 2025 07:00:00 GMT
• 3 tech stocks with high and rising institutional interest The Globe and Mail Thu, 19 Jun 2025 07:00:00 GMT
• Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data Endpoints News Fri, 13 Jun 2025 07:00:00 GMT
• us fda puts on hold rein therapeutics' lung disease drug trial MarketScreener Thu, 12 Jun 2025 07:00:00 GMT
• rein therapeutics pauses dosing in lung disease trial after us fda places hold MarketScreener Thu, 12 Jun 2025 07:00:00 GMT
• rein therapeutics paused its phase 2 renew trial of lti-03 in the u.s. MarketScreener Thu, 12 Jun 2025 07:00:00 GMT
• peripheral t-cell lymphoma (ptcl) drugs market 2034: clinical openPR.com Fri, 06 Jun 2025 05:44:00 GMT
• rein therapeutics announces first patient dosed in renew phase 2 trial of lti-03 in patients with ipf marketscreener.com Tue, 27 May 2025 07:00:00 GMT
• advancing oxygen-based therapies: hypoxia treatment market openPR.com Thu, 22 May 2025 10:36:00 GMT
• rein therapeutics reports first quarter 2025 financial results and provides business update PR Newswire Thu, 15 May 2025 07:00:00 GMT
• rein therapeutics announces initiation of renew phase 2 trial of lti-03 in patients with ipf marketscreener.com Mon, 12 May 2025 11:01:11 GMT
• rein therapeutics announces initiation of renew phase 2 trial of lti-03 in patients with ipf marketscreener.com Fri, 09 May 2025 07:00:00 GMT
• rein therapeutics and qureight ltd announce planned integration of deep-learning platform for phase 2 trial of lti-03 in patients ... marketscreener.com Thu, 01 May 2025 07:00:00 GMT
• united airlines stock analysis: buy, hold, or sell after evaluating risks The Globe and Mail Wed, 30 Apr 2025 07:00:00 GMT
• rein therapeutics to present at the citizens life sciences conference 2025 marketscreener.com Wed, 30 Apr 2025 07:00:00 GMT
• Aileron Therapeutics (ALRN) Stock Price, News & Analysis Stock Titan Thu, 24 Apr 2025 23:17:24 GMT
• alrn stock price, news & analysis | aileron therapeutics Stock Titan Thu, 24 Apr 2025 23:17:24 GMT
• alrn - aileron therapeutics inc latest stock news & market updates Stock Titan Thu, 24 Apr 2025 23:17:24 GMT
• rein therapeutics granted two patents covering the novel formulation and administration methods of dry powder lti-03 for treatment... marketscreener.com Wed, 23 Apr 2025 11:05:17 GMT
• s&p 500 index dips on nvidia’s china chip ban update The Globe and Mail Wed, 16 Apr 2025 07:00:00 GMT
• csx (csx) reports q1: everything you need to know ahead of earnings The Globe and Mail Tue, 15 Apr 2025 07:00:00 GMT
• rein therapeutics announces a publication in biomedicines on the immunomodulatory and anti-fibrotic properties of a caveolin-1-rel... PR Newswire Tue, 15 Apr 2025 07:00:00 GMT
• broadcom shared amazing news with semiconductor investors The Globe and Mail Wed, 09 Apr 2025 07:00:00 GMT
• rein's ipf drug shows promise: 4 biomarkers hit statistical significance in phase 1b Stock Titan Mon, 07 Apr 2025 07:00:00 GMT
• rein therapeutics reports fourth quarter and full year 2024 financial results and provides business update PR Newswire Mon, 07 Apr 2025 07:00:00 GMT
• aileron therapeutics, inc. announces new appointments MarketScreener Thu, 03 Apr 2025 10:34:53 GMT
• peripheral t-cell lymphoma treatment market 2034: clinical trials, ema, pdma, fda approvals, medication, revenue, statistics, comp... The Globe and Mail Fri, 28 Mar 2025 07:00:00 GMT
• firing on all cylinders: benchmark (nyse:bhe) q4 earnings lead the way The Globe and Mail Wed, 26 Mar 2025 09:03:00 GMT
• are xpeng (xpev) traders overpricing options ahead of q4 earnings? The Globe and Mail Mon, 17 Mar 2025 07:00:00 GMT
• chemotherapy induced anemia drugs market 2032: ema, pdma, fda approvals, clinical trials, medication, prevalence, nda approvals, t... The Globe and Mail Mon, 17 Feb 2025 22:40:43 GMT
• hypoxia treatment market to witness substantial growth by 2031 | openPR Mon, 10 Feb 2025 19:17:00 GMT
• theratechnologies (nasdaq:thtx) vs. aileron therapeutics (nasdaq:alrn) head to head survey Defense World Wed, 05 Feb 2025 08:00:00 GMT
• Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust GlobeNewswire Tue, 28 Jan 2025 08:00:00 GMT
• rodman & renshaw sets $8 target for rein therapeutics stock Investing.com Tue, 28 Jan 2025 08:00:00 GMT
• aileron therapeutics, inc. announced that it has received $42 million in funding from a group of investors. Marketscreener.com Wed, 22 Jan 2025 14:33:07 GMT
• chemotherapy induced anemia therapeutics market size in the 7mm is expected to grow by 2032, estimates delveinsight The Globe and Mail Tue, 21 Jan 2025 00:05:50 GMT
• chemotherapy induced anemia therapeutics market size in the 7mm is expected to grow by 2032, estimates delveinsight The Globe and Mail Mon, 20 Jan 2025 23:25:41 GMT
• Aileron straps in for 2025 with a new name: Rein Therapeutics Fierce Pharma Thu, 16 Jan 2025 08:00:00 GMT
• aileron therapeutics and advancium health network announce an exclusive option agreement for the acquisition of alrn-6924 for reti... Marketscreener.com Tue, 14 Jan 2025 06:33:29 GMT
• aileron therapeutics, inc. announces board changes -april 01, 2019 at 06:16 am edt Marketscreener.com Tue, 14 Jan 2025 04:30:13 GMT
• aileron therapeutics to be included in the russell microcap® index Marketscreener.com Tue, 14 Jan 2025 04:26:29 GMT
• aileron therapeutics announces appointments to scientific advisory board Marketscreener.com Tue, 14 Jan 2025 04:15:11 GMT
• aileron therapeutics announces the promotion of richard j. wanstall to chief financial officer and treasurer Marketscreener.com Tue, 14 Jan 2025 04:09:45 GMT
• aileron therapeutics announces board appointments Marketscreener.com Tue, 14 Jan 2025 04:07:13 GMT
• aileron therapeutics to present at the canaccord genuity 44th annual growth conference Marketscreener.com Tue, 14 Jan 2025 04:05:23 GMT
• aileron therapeutics reports second quarter 2024 financial results and business highlights Marketscreener.com Tue, 14 Jan 2025 04:02:50 GMT
• aileron therapeutics, inc. announces management changes Marketscreener.com Tue, 14 Jan 2025 04:02:38 GMT
• aileron therapeutics announces management changes Marketscreener.com Tue, 14 Jan 2025 03:59:03 GMT
• immunovant’s $450m private placement; biomea becomes an obesity biotech Endpoints News Mon, 13 Jan 2025 08:00:00 GMT
• rein therapeutics announces name change and new ticker Investing.com Mon, 13 Jan 2025 08:00:00 GMT
• geode capital management llc grows position in aileron therapeutics, inc. (nasdaq:alrn) Defense World Sat, 11 Jan 2025 08:00:00 GMT
• Aileron Therapeutics Announces Rebranding to Rein Therapeutics PR Newswire Fri, 10 Jan 2025 08:00:00 GMT
• rein therapeutics rebrands and focuses on pulmonary and fibrosis therapies Nasdaq Fri, 10 Jan 2025 08:00:00 GMT
• aileron rebrands as rein therapeutics following breakthrough ipf drug trial success Stock Titan Fri, 10 Jan 2025 08:00:00 GMT
• rntx - rein therapeutics, inc. latest stock news & market updates StockTitan Fri, 10 Jan 2025 08:00:00 GMT
• is raytheon the best defense and aerospace stock to own in 2025? The Globe and Mail Tue, 07 Jan 2025 08:00:00 GMT
• Aileron Therapeutics (NASDAQ: ALRN) - Share Price intelligentinvestor.com.au Sat, 28 Dec 2024 17:04:49 GMT
• aileron therapeutics to present at the 8th annual ipf summit The Eastern Progress Online Fri, 13 Dec 2024 00:15:02 GMT
• aileron therapeutics to present at the 8th annual ipf summit The Eastern Progress Online Thu, 12 Dec 2024 20:34:06 GMT
• aileron therapeutics to present at the 8th annual ipf summit The Eastern Progress Online Tue, 10 Dec 2024 16:35:49 GMT
• aileron therapeutics ceo james brian windsor buys $897 in stock by investing.com Investing.com Canada Tue, 10 Dec 2024 01:58:27 GMT
• aileron therapeutics ceo james brian windsor buys $897 in stock Investing.com Mon, 09 Dec 2024 08:00:00 GMT
• aileron therapeutics completes enrollment in cohort 2 of the ongoing phase 1b clinical trial evaluating lti-03 in idiopathic pulmo... The Eastern Progress Online Sat, 07 Dec 2024 02:08:21 GMT
• university of texas/texas a&m sells aileron therapeutics stock by investing.com Investing.com Nigeria Fri, 06 Dec 2024 08:00:00 GMT
• aileron therapeutics, inc. (nasdaq:alrn) sees significant decrease in short interest MarketBeat Sat, 30 Nov 2024 08:00:00 GMT
• aileron therapeutics reports third quarter 2024 financial results and recent business highlights Citizentribune Tue, 19 Nov 2024 11:35:30 GMT
• aileron therapeutics, inc. (nasdaq:alrn) short interest down 8.7% in october MarketBeat Sun, 17 Nov 2024 08:00:00 GMT
• Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights PR Newswire Thu, 14 Nov 2024 08:00:00 GMT
• aileron reports positive phase 1b data for ipf drug, shows strong biomarker response StockTitan Thu, 14 Nov 2024 08:00:00 GMT
• aileron's ipf drug shows promising results: 7 of 8 biomarkers improve in phase 1b trial | alrn stock news StockTitan Wed, 13 Nov 2024 12:00:00 GMT
• aileron therapeutics announces positive topline data from cohort GuruFocus Wed, 13 Nov 2024 08:00:00 GMT
• aileron therapeutics' investigational drug shows encouraging action in lung fibrosis Yahoo Finance Wed, 13 Nov 2024 08:00:00 GMT
• aileron reports promising phase 1b trial results for ipf treatment Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• aileron reports results from cohort 2 of its phase 1b clinical trial of lti-03 TipRanks Wed, 13 Nov 2024 08:00:00 GMT
• steve kafka joins section 32 as managing partner; takeda auctions off $660m drug portfolio in bid to reduce post-shire m&a debt lo... Endpoints News Wed, 06 Nov 2024 08:00:00 GMT
• advancium explores alrn-6924 for pediatric eye cancer treatment Investing.com India Fri, 01 Nov 2024 08:32:17 GMT
• aileron therapeutics and advancium health network announce an exclusive option agreement for the acquisition of alrn-6924 for reti... PR Newswire Thu, 31 Oct 2024 07:00:00 GMT
• advancium explores alrn-6924 for pediatric eye cancer treatment Investing.com Thu, 31 Oct 2024 07:00:00 GMT
• aileron therapeutics’ alrn-6924 to be acquired by advancium health network TipRanks Thu, 31 Oct 2024 07:00:00 GMT
• short interest in aileron therapeutics, inc. (nasdaq:alrn) drops by 14.2% MarketBeat Tue, 29 Oct 2024 07:00:00 GMT
• kck ltd.'s strategic reduction in neuropace inc shares Yahoo Finance Mon, 28 Oct 2024 07:00:00 GMT
• constrained peptide drugs market size, scope and share analysis InsightAce Analytic Mon, 28 Oct 2024 07:00:00 GMT
• earnings to watch: tesla (tsla) reports q3 results tomorrow The Globe and Mail Tue, 22 Oct 2024 07:00:00 GMT
• short interest in aileron therapeutics, inc. (nasdaq:alrn) increases by 15.8% MarketBeat Mon, 14 Oct 2024 12:03:40 GMT
• aileron therapeutics, inc. (nasdaq:alrn) short interest update MarketBeat Mon, 14 Oct 2024 12:03:40 GMT
Aileron Therapeutics, Inc(NASDAQ:ALRN) 
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the trea...
Website: http://www.aileronrx.com
Founded: 2001
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology